James P. Thomas

7.5k total citations · 3 hit papers
97 papers, 5.4k citations indexed

About

James P. Thomas is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, James P. Thomas has authored 97 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Oncology, 31 papers in Pulmonary and Respiratory Medicine and 24 papers in Surgery. Recurrent topics in James P. Thomas's work include Pancreatic and Hepatic Oncology Research (20 papers), Colorectal Cancer Treatments and Studies (17 papers) and Voice and Speech Disorders (15 papers). James P. Thomas is often cited by papers focused on Pancreatic and Hepatic Oncology Research (20 papers), Colorectal Cancer Treatments and Studies (17 papers) and Voice and Speech Disorders (15 papers). James P. Thomas collaborates with scholars based in United States, United Kingdom and Canada. James P. Thomas's co-authors include Albert W. Girotti, Al B. Benson, Leonard B. Saltz, Donna Niedzwiecki, Robert J. Mayer, Donna Hollis, Jordan Berlin, Alexander Hantel, Paul J. Catalano and Daniel G. Haller and has published in prestigious journals such as JAMA, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

James P. Thomas

93 papers receiving 5.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Phase III Study of Gemcitabine in Combination With Fluorouracil Versus Gemcitabine Alone in Patients With Advanced Pancreatic Carcinoma: Eastern Cooperative Oncology Group Trial E2297

2002 602 citations Jordan Berlin, James P. Thomas et al. Journal of Clinical Oncology profile →
Impact of Physical Activity on Cancer Recurrence and Survival in Patients With Stage III Colon Cancer: Findings From CALGB 89803

2006 537 citations Jeffrey A. Meyerhardt, Donna Niedzwiecki et al. Journal of Clinical Oncology profile →
Recommendations for Radioembolization of Hepatic Malignancies Using Yttrium-90 Microsphere Brachytherapy: A Consensus Panel Report from the Radioembolization Brachytherapy Oncology Consortium

2007 511 citations Andrew S. Kennedy, Subir Nag et al. International Journal of Radiation Oncology*Biology*Physics profile →

Peers

Countries citing papers authored by James P. Thomas

Since Specialization

Citations

This map shows the geographic impact of James P. Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James P. Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James P. Thomas more than expected).

Fields of papers citing papers by James P. Thomas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James P. Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James P. Thomas. The network helps show where James P. Thomas may publish in the future.

Co-authorship network of co-authors of James P. Thomas

This figure shows the co-authorship network connecting the top 25 collaborators of James P. Thomas. A scholar is included among the top collaborators of James P. Thomas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James P. Thomas. James P. Thomas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Microglia positron emission tomography and progression in multiple sclerosis: thalamus on fire 2025 ·Brain Communications ·Burcu Zeydan, (unknown), (unknown), Christopher G. Schwarz, James P. Thomas, Holly A. Morrison, Max Bush, Robert I. Reid, Scott A. Przybelski, Angela J. Fought, Clifford R. Jack, Ronald C. Petersen, Kejal Kantarci, Val J. Lowe, Laura Airas, Orhun H. Kantarci	4
2	ATM or CHEK2 alterations: Potential biomarkers of improved outcomes with irinotecan-containing chemotherapy in advanced pancreatic ductal adenocarcinoma. 2023 ·Journal of Clinical Oncology ·(unknown), Bicky Thapa, Anikó Szabó, Gulrayz Ahmed, Aditya Shreenivas, James P. Thomas, (unknown), Douglas B. Evans, Susan Tsai, Kathleen K. Christians, Beth Erickson, William A. Hall, (unknown), Steve M. Patrick, Ben George, Razelle Kurzrock, Mandana Kamgar	1
3	Social Perception of External Laryngeal Anatomy Related to Gender Expression in a Web‐based Survey 2022 ·The Laryngoscope ·(unknown), Karthik Balakrishnan, Alex Fauer, (unknown), Daniella McDonald, James P. Thomas, Elizabeth Erickson, C. Kwang Sung, (unknown)	2
4	Feminization Laryngoplasty - A Comprehensive Approach to Reducing the Size of the Larynx and Pharynx 2022 ·Otolaryngologic Clinics of North America ·James P. Thomas	3
5	p38γ MAPK Is Essential for Aerobic Glycolysis and Pancreatic Tumorigenesis 2020 ·Cancer Research ·Fang Wang, Xiao-Mei Qi, (unknown), (unknown), Catherine E. Hagen, John Evans, Yuri Sheinin, Michael A. James, Pengyuan Liu, Susan Tsai, James P. Thomas, Alexander C. Mackinnon, Michael B. Dwinell, Charles R. Myers, Ramón Bartrons, Liwu Fu, Guan Chen	63
6	Visual Neurolaryngology 2020 ·Advances in oto-rhino-laryngology ·James P. Thomas	0
7	A Comprehensive Program for the Enhancement of Accrual to Clinical Trials 2016 ·Annals of Surgical Oncology ·(unknown), Bhuvaneswari Ramaswamy, (unknown), (unknown), (unknown), James P. Thomas, (unknown), Michael A. Caligiuri, William E. Carson	8
8	p38γ MAPK is required for inflammation-associated colon tumorigenesis 2015 ·Oncogene ·Ning Yin, X. Sharon Qi, Susan Tsai, Yangcheng Lü, Zainab Basir, Kiyoko Oshima, James P. Thomas, Charles R. Myers, Gary D. Stoner, (unknown)	36
9	Tumor profiling of gastric and esophageal carcinoma reveal different treatment options 2015 ·Cancer Biology & Therapy ·John T. Miura, Joanne Xiu, James P. Thomas, Ben George, (unknown), Susan Tsai, Fabian M. Johnston, Kiran K. Turaga, T. Clark Gamblin	15
10	The combination of a chemotherapy doublet (gemcitabine and capecitabine) with a biological doublet (bevacizumab and erlotinib) in patients with advanced pancreatic adenocarcinoma. The results of a phase I/II study 2014 ·European Journal of Cancer ·David Watkins, Naureen Starling, David Cunningham, James P. Thomas, (unknown), Gina Brown, Yolanda Barbáchano, J. Oates, Ian Chau	23
11	Review of the Impact of Antineoplastic Therapies on the Risk for Cholelithiasis and Acute Cholecystitis 2013 ·Annals of Surgical Oncology ·Thejus Jayakrishnan, Ryan T. Groeschl, Ben George, James P. Thomas, T. Clark Gamblin, Kiran K. Turaga	14
12	A Phase II Study of Oxaliplatin, 5-Fluorouracil, Leucovorin, and High-Dose Capecitabine in Patients With Metastatic Colorectal Cancer 2010 ·Clinical Colorectal Cancer ·Sam Joseph Lubner, Noelle K. LoConte, Kyle D. Holen, William R. Schelman, James P. Thomas, (unknown), Jens C. Eickhoff, Songwon Seo, Daniel Mulkerin	6
13	Cytotoxic evaluation of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone in peripheral blood lymphocytes of patients with refractory solid tumors using electron paramagnetic resonance 2010 ·Experimental and Therapeutic Medicine ·Jill Kolesar, Kamakshi Sachidanandam, William R. Schelman, Jens C. Eickhoff, Kyle D. Holen, Anne M. Traynor, Dona Alberti, James P. Thomas, Christopher R. Chitambar, George Wilding, William E. Antholine	7
14	Randomized Double-Blind Phase II Trial Comparing Gemcitabine Plus LY293111 Versus Gemcitabine Plus Placebo in Advanced Adenocarcinoma of the Pancreas 2009 ·The Cancer Journal ·Muhammad Wasif Saif, Helmut Oettle, Walter L. Vervenne, James P. Thomas, Gary Spitzer, Carla Visseren‐Grul, Nathan Enas, Donald Richards	44
15	Fixed-Dose-Rate Gemcitabine in Combination with Oxaliplatin in Patients with Metastatic Pancreatic Cancer Refractory to Standard-Dose-Rate Gemcitabine: A Single-Institute Study 2009 ·Oncology ·Brett E. Fortune, Xiaobai Li, (unknown), (unknown), James P. Thomas, Tanios Bekaii‐Saab	18
16	Association of Dietary Patterns With Cancer Recurrence and Survival in Patients With Stage III Colon Cancer 2008 ·Obstetrical & Gynecological Survey ·Jeffrey A. Meyerhardt, Donna Niedzwiecki, Donna Hollis, Leonard B. Saltz, Frank B. Hu, Robert J. Mayer, Heidi Nelson, Renaud Whittom, Alexander Hantel, James P. Thomas, Charles S. Fuchs	20
17	Electron paramagnetic resonance study of peripheral blood mononuclear cells from patients with refractory solid tumors treated with Triapine® 2007 ·Journal of Inorganic Biochemistry ·Jill Kolesar, William R. Schelman, Peter Geiger, Kyle D. Holen, Anne M. Traynor, Dona Alberti, James P. Thomas, Christopher R. Chitambar, George Wilding, William E. Antholine	29
18	Recommendations for Radioembolization of Hepatic Malignancies Using Yttrium-90 Microsphere Brachytherapy: A Consensus Panel Report from the Radioembolization Brachytherapy Oncology Consortium breakdown → 2007 ·International Journal of Radiation OncologyBiologyPhysics ·Andrew S. Kennedy, Subir Nag, Riad Salem, Ravi Murthy, Alexander McEwan, Charles Nutting, Al B. Benson, Joseph Espat, José Ignacio Bilbao, Ricky A. Sharma, James P. Thomas, Douglas M. Coldwell	511
19	Phase II Study of Gemcitabine in Combination with Docetaxel in Patients with Advanced Pancreatic Carcinoma (E1298) 2004 ·Oncology ·Robert Shepard, Donna E. Levy, Jordan Berlin, Keith Stuart, Jules E. Harris, (unknown), James P. Thomas, Al B. Benson	26
20	Photooxidation of cell membranes in the presence of hematoporphyrin derivative: reactivity of phospholipid and cholesterol hydroperoxides with glutathione peroxidase 1988 ·Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism ·James P. Thomas, Albert W. Girotti	51

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact